Sunil Agarwal serves as Executive at Ultragenyx Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, Sunil Agarwal has executed 51 insider transactions totaling $4.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 19, 2014 involved receiving (via award) 25,000 shares valued at $0.
Sunil Agarwal currently holds 14,141 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sunil Agarwal has been a net seller of RARE stock. They have purchased $0 and sold $4.3M worth of shares.
Sunil Agarwal's most recent insider trade was on Aug 19, 2014, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted